Curated News
By: NewsRamp Editorial Staff
March 09, 2026

HeartBeam Showcases Revolutionary 3D ECG Tech at Major 2026 Conferences

Discuss on LinkedIn Discuss on Telegram View History of this news story on GitHub
Original Source

TLDR

  • HeartBeam's conference participation offers investors early access to its FDA-cleared 3D ECG technology, potentially gaining an edge in the growing cardiac monitoring market.
  • HeartBeam executives will attend three March 2026 conferences to present their FDA-cleared 3D ECG system and demonstrate a 12-lead ECG patch prototype to investors and physicians.
  • HeartBeam's portable 3D ECG technology enables remote cardiac monitoring, improving early detection of heart conditions and expanding access to care outside medical facilities.
  • HeartBeam's cable-free 3D ECG device captures heart signals from three directions, creating the first portable system that synthesizes a full 12-lead ECG anywhere.

Impact - Why it Matters

This development matters because it represents a significant leap in accessible cardiac monitoring, potentially impacting millions with heart conditions. Traditional ECG systems are often confined to clinical settings, creating barriers for timely diagnosis and continuous monitoring. HeartBeam's portable, cable-free 3D technology could democratize cardiac care by allowing accurate, 12-lead ECG data collection anywhere—at home, work, or during travel. This addresses critical gaps in managing conditions like arrhythmias, where early detection is vital for preventing strokes or heart failure. By enabling remote monitoring, it may reduce hospital visits, lower healthcare costs, and empower patients with real-time insights into their heart health. For the medical community, it offers a tool to track trends and intervene proactively, shifting cardiac care from reactive to preventive. In an aging global population with rising cardiovascular disease rates, such innovations are crucial for improving outcomes and quality of life.

Summary

HeartBeam, Inc. (NASDAQ: BEAT), a pioneering medical technology company, is taking its transformative cardiac care solutions directly to key financial and medical audiences this March 2026. The company's leadership team, including CEO Robert Eno and CFO Timothy Cruickshank, will engage with investors at prominent conferences such as the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference and the 38th Annual ROTH Conference in Dana Point, California. At these events, they will present the company's vision and meet with institutional and retail investors, while Eno will also contribute to a panel discussion on technologies advancing healthy aging at the ROTH Conference.

The strategic outreach culminates at ACC.26, the American College of Cardiology's annual scientific conference, where Founder and President Dr. Branislav Vajdic and Chief Commercial Officer Bryan Humbarger will join Eno. This is a critical platform for the company to showcase its FDA-cleared HeartBeam System and demonstrate a working prototype of its groundbreaking 12-lead ECG extended wear patch to physicians and potential industry partners. The company's presence at these events underscores its commitment to advancing cardiac health management outside traditional medical facilities.

HeartBeam's core innovation is its platform technology, which represents the first-ever cable-free device capable of collecting ECG signals in 3D from three non-coplanar directions and synthesizing them into a 12-lead ECG. This technology, which received FDA clearance for arrhythmia assessment in December 2024 and for its 12-lead ECG synthesis software in December 2025, is designed to deliver actionable heart intelligence from portable devices used wherever the patient is. With over 20 issued patents, the company is redefining cardiac care by enabling physicians to identify health trends and acute conditions remotely, potentially directing patients to appropriate care more efficiently. For more details, the full press release is available via the provided link to view the original release on www.newmediawire.com, and the latest updates relating to BEAT can be found in the company's newsroom.

Source Statement

This curated news summary relied on content disributed by NewMediaWire. Read the original source here, HeartBeam Showcases Revolutionary 3D ECG Tech at Major 2026 Conferences

blockchain registration record for this content.